Filing Details

Accession Number:
0001209191-22-057002
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-15 16:29:21
Reporting Period:
2022-11-11
Accepted Time:
2022-11-15 16:29:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
924717 Surmodics Inc SRDX Surgical & Medical Instruments & Apparatus (3841) 411356149
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198349 Sr B Ronald Kalich 9924 West 74Th Street
Eden Prairie MN 55344
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-11 4,366 $20.18 32,912 No 4 M Direct
Common Stock Disposition 2022-11-11 2,733 $33.48 30,179 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-11-11 4,366 $0.00 4,366 $20.18
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-12-18 No 4 M Direct
Footnotes
  1. Reflects the weighted average price of 2,733 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on November 11, 2022 with sale prices ranging from $33.40 to $33.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. The amount beneficially owned includes 10,113 restricted stock units (RSUs) that vest on service-based vesting dates and 12,016 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
  3. Fully vested.